About: Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article by E P Sampaio et al published February 1998 in Clinical and Experimental Immunology

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 1998 (uk) article scientifique publié en 1998 (fr) im Februar 1998 veröffentlichter wissenschaftlicher Artikel (de) article by E P Sampaio et al published February 1998 in Clinical and Experimental Immunology (en)
publication date	wds:Q62731355-9192C3AE-5409-4781-9190-560D3B78AB7C
publication date	1998-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q62731355-DD2B5674-5873-4B3A-97C6-B6553818625C
language of work or name	English
cites work	wds:Q62731355-00035CFE-3115-4753-A13B-467F80844D65 wds:Q62731355-06262644-5160-40F6-AAA0-F5D78DBD2AB5 wds:Q62731355-0DFA3D66-5504-43F5-BC2B-F9226103EE23 wds:Q62731355-0E03E354-876E-4707-A8A6-FA0CFE379D0A wds:Q62731355-0EF60C99-2E4F-4FBF-AF11-897D688A575C wds:Q62731355-121A52E9-D32A-491D-8833-AF85DD779510 wds:Q62731355-21FC1286-89FC-4F55-B8AB-F836353AEB75 wds:Q62731355-338422FE-311D-4D9A-99FA-0B7D91BC5381 wds:Q62731355-34417339-26B6-4A6A-A410-8438412DCC9A wds:Q62731355-3A0860C3-0CE9-4DD1-8A30-F15B5E4E56E2 wds:Q62731355-44B4C5AB-DD6C-4C4B-AB49-B76CEE918F39 wds:Q62731355-478ED8F5-582B-44AE-B264-0F61FE406AAC wds:Q62731355-5066742B-C355-465E-83A7-AB7510437276 wds:Q62731355-518825D1-F391-4CA4-AF0B-B93D7FF6EEA2 wds:Q62731355-59939EDF-C908-4787-A7FF-133734EC935D wds:Q62731355-68A08C8A-4EE1-4455-B0BD-6C536FFA7544 wds:Q62731355-7173726E-859A-461B-9B85-F7E00CF7AF7C wds:Q62731355-7343D20A-D232-43B8-B9B4-0979A0EE8923 wds:Q62731355-74938C07-24A1-408A-A701-6E55DFF5F665 wds:Q62731355-74F14D2E-4DA9-40A8-9F57-4F63E1AF77D4 wds:Q62731355-95906BD6-AEAC-48E7-A056-DFCE75E215AB wds:Q62731355-A1B51AF4-B255-444A-BB93-E55AC7561A2E wds:Q62731355-AA7C0832-409F-4772-980A-B532AB768EDE wds:Q62731355-AEEC6544-53FF-4ADF-9A17-315769B25603 wds:Q62731355-B984FA0E-598D-4F5E-9194-4F6DDB297A92 wds:Q62731355-BF05C772-488A-435F-808D-61A48AD77D6D wds:Q62731355-C7655913-8348-4706-8E50-69E4C0303BC7 wds:Q62731355-CDF83270-B5C7-4064-817D-2C2671E33B20 wds:Q62731355-D4B66AFE-34EB-47F4-87A8-3DC656C1F3AF wds:Q62731355-DCE4195A-41EA-4D02-94E3-E311AE7C58D1 wds:Q62731355-DE75BB66-3A7A-40BE-821C-993D2AAB2EED wds:Q62731355-E71E8D5D-3200-4BBD-96FC-D3A635EF2BE0 wds:Q62731355-E919E189-8081-4063-8206-CBF63987ECA8 wds:Q62731355-EBA93568-5908-4529-A6EA-EBA63D85B011 wds:Q62731355-ED00A777-A8AD-47C1-9177-54263FE43FDA wds:Q62731355-F67291CB-F4DD-4543-8DB7-E2C575B06553 wds:Q62731355-F895EAD0-F098-4F66-B0CD-1647952F9DBB
cites work	Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes Classification of leprosy according to immunity. A five-group system Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients Inhibition of endogenous TNF formation by pentoxifylline Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis IL-10 inhibits cytokine production by activated macrophages Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NF-kappa B action. Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. NIAID AIDS Clinical Trials Group. Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory Oxpentifylline in endotoxaemia. Biological properties of interleukin 10. Defining protective responses to pathogens: cytokine profiles in leprosy lesions Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum Leprosum Pentoxifylline suppression of tumor necrosis factor gene transcription Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis Tumour necrosis factor-alpha (TNF-alpha) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions Pentoxifylline Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline Pentoxifylline, pentifylline, and interferons decrease type I and III procollagen mRNA levels in dermal fibroblasts: evidence for mediation by nuclear factor 1 down-regulation Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-alpha and interleukin-1 beta by human mononuclear cells Pentoxifylline and wellbeing in patients with cancer Serum tumor necrosis factor and interleukin 1 in leprosy and during lepra reactions Clinical and histological discrepancies in diagnosis of ENL reactions classified by assessment of acute phase proteins SAA and CRP Development of giant reaction in response to PPD skin test in lepromatous leprosy patients Tumor necrosis factor production in patients with leprosy Pentoxifylline in cerebral malaria. Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: a pilot study Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum The role of inflammatory cytokines in the tissue injury of leprosy Pentoxifylline inhibits acute HIV-1 replication in human T cells by a mechanism not involving inhibition of tumour necrosis factor synthesis or nuclear factor-kappa B activation Is pentoxifylline a viable alternative in the treatment of ENL?
author name string	wds:Q62731355-11FDA0CD-C05D-4E62-A0EF-7685DDACE1D4 wds:Q62731355-4947EC46-B0C5-4CB1-ADC0-D3C1D7270519 wds:Q62731355-5B8762CB-507A-40FC-9B49-6CBCC45DF3B6 wds:Q62731355-88B37E74-1967-4653-9F3C-60DA64AA1A4E wds:Q62731355-9B6211B3-CED2-4B29-AF6E-01B54EE7D139 wds:Q62731355-AEDA9893-0EC2-4D9A-B699-09E32A3970D3
author name string	A R Santos E N Sarno M O Moraes E P Sampaio J A Nery H C Matos
rdfs:label	Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL) (en) Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (nl)
skos:prefLabel	Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL) (en) Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (nl)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software